Total Funding
53
45
Total FundingPost-IPO Equity raised
Growth Score
-5 pts
Heat Score
8 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
119600
Xenetic Biosciences is a biopharmaceutical company that provides drugs, cancer therapies, and vaccines.
- James F. Parslow: Chief Financial OfficerPast Role: World Energy Solutions, Chief Financial Officer
- James F. Parslow: Interim CEOPast Role: World Energy Solutions, Chief Financial Officer
About the Company
Xenetic is a leading UK-based biopharmaceutical company providing leading-edge expertise in the development of a whole new generation of drugs, cancer therapies, and vaccines.
Xenetic Biosciences is formerly known as Lipoxen. Working with some of the largest pharmaceutical organizations in the world, Xenetic provides specialist delivery solutions
to improve the efficacy and performance of drugs and vaccines in a number of key medical areas including oncology.
